Friday, July 10, 2026

pharma · acute pharyngitis

MEDICE Arzneimittel Pütter

Medice Arzneimittel Pütter is a pharma organization headquartered in Iserlohn, DE. Primary therapeutic focus areas include acute pharyngitis. NovaPharmaNews links 3 clinical program(s), 0 drug profile(s), and 0 patent re

Iserlohn, DE HQ
1949 Founded
600 Employees
EMA registrant Type
Company details
Status
Public
HQ
Iserlohn, DE
Founded
1949
Employees
600
Programs
3
Drugs
6
Patents
0

Quick answer

Medice Arzneimittel Pütter is a pharma organization headquartered in Iserlohn, DE. Primary therapeutic focus areas include acute pharyngitis. NovaPharmaNews links 3 clinical program(s), 0 drug profile(s), and 0 patent record(s) to this entity from public FDA, EMA, ClinicalTrials.gov, and USPTO sources. Pipeline phase mix: phase 3 (3).

Company snapshot

Seit über 75 Jahren steht MEDICE als familiengeführtes Unternehmen für das Ziel, die Gesundheit der Menschen zu verbessern – unter Einbezug physischer, psychischer, sozialer und ökologischer Aspekte. Die meisten Kinder, Jugendlichen und Erwachsenen mit ADHS in Deutschland und Europa werden seit vielen Jahren mit Arzneimitteln der MEDICE behandelt (1). Mit innovativen Angeboten im Bereich Renal Car

  • 3 active pipeline program(s) linked via ClinicalTrials.gov.
  • 3 trial update(s) in the last 12 months.

Public regulatory, clinical, patent, and corporate records for MEDICE Arzneimittel Pütter. Not investment advice.

Lead pipeline drugs

Active clinical programs

Momentum

Proprietary activity score for MEDICE Arzneimittel Pütter.

0 /100 +0 vs 30 days ago

Signal breakdown

  • Clinical trials 0 30d
  • Nova articles 0 30d
  • Patents filed 0 30d
  • FDA actions 0 30d
  • SEC filings 0 30d
  • Conference presentations 0 90d
  • Pipeline advances 0 30d

Recent activity

Latest pipeline, patent, and corporate events for MEDICE Arzneimittel Pütter.

  1. Clinical update

    6520-9970-08 — Phase 3

  2. Clinical update

    6630-9450-01 — Phase 3

  3. Clinical update

    6630-9450-01 — Phase 3

View all clinical trial activity →

Quick answers

Common questions about this sponsor — for analysts and search.

  • What is MEDICE Arzneimittel Pütter?

    Medice Arzneimittel Pütter is a pharma organization headquartered in Iserlohn, DE. Primary therapeutic focus areas include acute pharyngitis. NovaPharmaNews links 3 clinical program(s), 0 drug profile(s), and 0 patent record(s) to this entity from public FDA, EMA, ClinicalTrials.

  • Is MEDICE Arzneimittel Pütter publicly traded?

    MEDICE Arzneimittel Pütter appears in our database through regulatory marketing authorisation or clinical trial sponsor records; a US listed ticker is not shown for this entity.

  • What drugs does MEDICE Arzneimittel Pütter develop or market?

    We link 6 drug profile(s) where MEDICE Arzneimittel Pütter is an originator or marketer in FDA or regional approval metadata. See the drug portfolio table on https://novapharmanews.com/companies/medice-arzneimittel-p-tter-gmbh-co-kg-eu#company-drugs.

  • What are the latest developments for MEDICE Arzneimittel Pütter?

    In the last 12 months our linked public records show 3 trial program update(s) and 0 US patent grant(s) tied to this profile.

  • What therapeutic areas does MEDICE Arzneimittel Pütter focus on?

    MEDICE Arzneimittel Pütter focuses on acute pharyngitis based on our analysis of their pipeline programs and drug development activities.

Therapeutic focus

Therapeutic area distribution

Pipeline concentration by therapeutic area from linked clinical programs.

Programs by therapeutic area

Others
4